Home・Listă Acțiuni・Ocugen Inc

Ocugen Inc

Închisă

1.21 -4.72

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

1.24

Maxim

1.31

Indicatori cheie
By Trading Economics
Venit	-1.5M -19M
Vânzări	1.7M 1.5M
EPS	-0.06
Marjă de profit	-1,250.946
Angajați	116
EBITDA	-987K -17M

Recomandări
By TipRanks
Recomandări	Puternic Cumpărare
Prognoză pe 12 luni	+667.46% upside

Dividende
By Acuity
Următoarele câștiguri	31 iul. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	-176M 450M
Deschiderea anterioară	5.93
Închiderea anterioară	1.21

Ocugen Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

27 iul. 2026, 23:56 UTC

eBay Inc. shares are trading lower in after-market hours, with no specific company news identified. The stock remains near the midpoint of its one-month trading range.

27 iul. 2026, 23:56 UTC

Steel Dynamics Inc shares are trading lower in after-market hours. No specific company news was identified to explain the price movement.

27 iul. 2026, 23:56 UTC

Alibaba Group Holding Ltd shows a slight gain in after-market trading, reflecting positive market sentiment. The stock remains above its 20-day moving average.

27 iul. 2026, 23:56 UTC

PepsiCo Inc. shares remained roughly flat during after-market hours, trading within a narrow range around the middle of their one-month range.

27 iul. 2026, 23:56 UTC

Monday.Com Ltd. shares are lower in after-market trading, fluctuating within a narrow range without specific news driving the decline.

27 iul. 2026, 23:56 UTC

Correlated Moves

Kulicke and Soffa Industries shares declined in after-market trading, reflecting broader weakness in the semiconductor sector and a drop in the Nasdaq 100 Index.

27 iul. 2026, 23:56 UTC

Madrigal Pharmaceuticals Inc is trading higher in after-market hours, reflecting a notable increase since Monday's close, despite no specific news identified.

27 iul. 2026, 23:56 UTC

Correlated Moves

News

Diamondback Energy gained during after-market hours, buoyed by strong revenue growth and a favorable market position, with shares peaking above Monday's close.

27 iul. 2026, 23:56 UTC

Under Armour Inc shares are lower in after-market trading, with no specific news identified to explain the decline. The stock remains above its 20-day moving average.

27 iul. 2026, 23:56 UTC

Whirlpool Corp shares are higher in after-market hours, reflecting a modest increase since Monday's close amid positive sentiment in European markets.

27 iul. 2026, 23:56 UTC

Archer-Daniels-Midland Co is rising in after-market trading, reversing three sessions of declines. No specific news was identified to explain this movement.

27 iul. 2026, 23:56 UTC

Matador Resources Co shares are higher in after-market trading following Monday's close, despite remaining below their 20-day moving average.

27 iul. 2026, 23:56 UTC

JD.Com Inc. shares declined in after-market trading, despite a strong one-month gain and trading above its 20-day moving average. No specific news was identified.

27 iul. 2026, 23:56 UTC

Correlated Moves

Costco shares are lower in after-market trading, following a slight decline in the Nasdaq 100 Index. The stock remains above its 20-day moving average.

27 iul. 2026, 23:56 UTC

Social Media

General Motors plans a $6 billion investment in U.S. manufacturing, including an expansion at its Orion Township plant. Shares are roughly flat in after-market trading.

27 iul. 2026, 23:56 UTC

Shell PLC shares showed little change in after-market trading. The stock remains above its 20-day moving average amid positive sentiment in European markets.

27 iul. 2026, 23:56 UTC

Viking Therapeutics Inc shares are lower in after-market hours, reflecting a lack of specific news and remaining below the 20-day moving average.

27 iul. 2026, 23:56 UTC

Trimble Inc shares are lower in after-market hours following Monday's close. The stock remains above its 20-day moving average despite the decline.

27 iul. 2026, 23:52 UTC

Mexico's Business Confidence Data Release on August 3, 2026, Expected to Reflect Cautious Sentiment Amid Global Market Volatility and Inflationary Pressures.

27 iul. 2026, 23:52 UTC

U.S. Initial Jobless Claims Expected at 204,000 Amid Positive Labor Market Sentiment and Fed Policy Speculation

27 iul. 2026, 23:52 UTC

Australia's Building Permits Expected to Decline by 0.5% in June Amidst Ongoing Weakness in Housing Construction and Elevated Borrowing Costs

27 iul. 2026, 23:52 UTC

Weis Markets shares declined after-market, remaining about 4.47% below their 20-day moving average. No specific news was identified to explain the movement.

27 iul. 2026, 23:52 UTC

Xylem Inc shares are higher in after-market trading, continuing a trend of four consecutive sessions of gains and remaining above the 20-day moving average.

27 iul. 2026, 23:51 UTC

Trustmark Corp shares are higher during after-market hours, moving from a low of -0.04% to a high of 0.95% since Monday's close.

27 iul. 2026, 23:51 UTC

Correlated Moves

Vanguard Total Bond Market ETF trades higher after-market, reflecting broader market trends amid easing geopolitical tensions and a drop in oil prices.

27 iul. 2026, 23:51 UTC

J B Hunt Transport Services Inc shares are lower in after-market hours, continuing a downward trend with no specific news identified to explain the movement.

27 iul. 2026, 23:51 UTC

Social Media

Correlated Moves

Shares lower in after-market trading; call writer profits $1.28 million.

27 iul. 2026, 23:51 UTC

Regeneron Pharmaceuticals shares are higher in after-market trading, maintaining momentum with strong cumulative returns and three consecutive higher daily closes.

27 iul. 2026, 23:51 UTC

News

Event

UDR Inc reported second-quarter net income of $69.035 million. Shares declined in after-market trading amid concerns over flat revenue and rising costs.

27 iul. 2026, 23:51 UTC

News

L3Harris Technologies has secured Pentagon agreements to boost missile defense production, but shares are trading lower in after-market hours.

Comparație

Modificare preț

Ocugen Inc Așteptări

Obiectiv de preț

By TipRanks

667.46% sus

Prognoză pe 12 luni

Medie 9.67 USD 667.46%

Maxim 12 USD

Minim 7 USD

În baza a 6 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruOcugen Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

6 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 6 analiști care au acordat evaluări ale acțiunilor Ocugen Inc - Dist în ultimele 3 luni.

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve patients' health. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, currently under Phase 3 trials for the treatment of retinitis pigmentosa and Phase 1/2 trials for the treatment of leber congenital amaurosis; OCU410, a gene therapy under phase 1/2 for the treatment of dry age-related macular degeneration (AMD); and OCU410ST, a gene therapy under phase 1/2 for the treatment of Stargardt disease. It is also involved in the development of OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet age-related macular degeneration; and NeoCart, an autologous chondrocyte-derived neocartilage, currently under Phase 3 studies indicated for the repair of knee cartilage injuries in adult. In addition, the company is developing OCU500, a COVID-19 vaccine; OCU510, a seasonal quadrivalent flu vaccine; and OCU520, a combination quadrivalent seasonal flu and COVID-19 vaccine. It has collaboration agreements with National Institute of Allergy and Infectious Diseases for early clinical studies for the OCU500 program; and a strategic partnership with CanSino Biologics Inc. for manufacturing its modifier gene therapy pipeline product candidates. The company was founded in 2013 and is headquartered in Malvern, Pennsylvania.